Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.06B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$1.87B |
| 3 |
Apple
AAPL
|
+$1.03B |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$747M |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$730M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$930M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$598M |
| 3 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$524M |
| 4 |
TSMC
TSM
|
+$363M |
| 5 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.47% |
| 2 | Healthcare | 9.44% |
| 3 | Financials | 9.02% |
| 4 | Consumer Discretionary | 7.88% |
| 5 | Industrials | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Regeneron Pharmaceuticals
REGN
$78.5B
| $298M | 0.08% |
431,915
+16,790
| +4% | +$10.6M |
|
252
ASML
ASML
$626B
| $297M | 0.08% |
715,644
+73,008
| +11% | +$36.6M |
|
253
Ascendis Pharma A/S
ASND
$16B
| $295M | 0.07% |
2,858,430
-457,785
| -14% | -$43.4M |
|
254
Goldman Sachs MarketBeta US Equity ETF
GSUS
$3.16B
| $294M | 0.07% |
6,037,156
-603,420
| -9% | -$32.7M |
|
255
O'Reilly Automotive
ORLY
$72.9B
| $294M | 0.07% |
6,262,740
-89,130
| -1% | -$4.16M |
|
256
Moody's
MCO
$82.8B
| $293M | 0.07% |
1,205,282
+87,908
| +8% | +$25.5M |
|
257
Dynatrace
DT
$12.9B
| $293M | 0.07% |
8,403,461
-285,702
| -3% | -$11M |
|
258
CALL
Toronto Dominion Bank
TD
$198B
| $292M | 0.07% |
+4,762,000
| New | +$308M |
|
259
Southern Company
SO
$109B
| $292M | 0.07% |
4,290,781
+260,279
| +6% | +$19.7M |
|
260
Cummins
CMI
$87.5B
| $291M | 0.07% |
1,432,311
+509,048
| +55% | +$108M |
|
261
Air Products & Chemicals
APD
$65.7B
| $290M | 0.07% |
1,247,940
+4,852
| +0.4% | +$1.2M |
|
262
Williams Companies
WMB
$87.5B
| $290M | 0.07% |
10,140,582
+141,938
| +1% | +$4.62M |
|
|
CCXI
263
DELISTED
ChemoCentryx, Inc.
CCXI
| $290M | 0.07% |
5,616,301
+5,138,232
| +1,075% | +$212M |
|
264
Stryker
SYK
$125B
| $289M | 0.07% |
1,428,855
+330,282
| +30% | +$69.5M |
|
265
CALL
iShares Silver Trust
SLV
$28B
| $287M | 0.07% |
16,428,100
+10,028,100
| +157% | +$178M |
|
266
Ambev
ABEV
$48.1B
| $287M | 0.07% |
101,252,870
+58,106,600
| +135% | +$165M |
|
267
TJX Companies
TJX
$174B
| $286M | 0.07% |
4,600,892
+257,751
| +6% | +$16.2M |
|
268
Kinder Morgan
KMI
$71.7B
| $286M | 0.07% |
17,165,725
+3,146,426
| +22% | +$55.9M |
|
269
Vanguard Morningstar Total Stock Market ETF
VTI
$660B
| $285M | 0.07% |
1,589,008
-161,572
| -9% | -$32.2M |
|
270
KKR & Co
KKR
$91.1B
| $284M | 0.07% |
6,615,792
+1,410,736
| +27% | +$71.3M |
|
271
CALL
Bank of America
BAC
$435B
| $283M | 0.07% |
9,358,000
-646,600
| -6% | -$21.6M |
|
272
iShares MSCI Pacific ex Japan ETF
EPP
$2.22B
| $282M | 0.07% |
7,525,902
+193,960
| +3% | +$8.09M |
|
273
Northrop Grumman
NOC
$77.1B
| $282M | 0.07% |
598,772
+85,168
| +17% | +$40.6M |
|
274
Duke Energy
DUK
$97.8B
| $281M | 0.07% |
3,022,834
+409,541
| +16% | +$44M |
|
275
iShares Semiconductor ETF
SOXX
$41.7B
| $279M | 0.07% |
2,624,850
+882,702
| +51% | +$111M |
|
Similar funds
Goldman Sachs's Q3 2022 Portfolio in Review
As of Q3 2022, Goldman Sachs held 6,885 positions worth $396B, down 1.1% from $400B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Goldman Sachs deployed $17.3B of net new capital in Q3 2022, opening 459 new positions and adding to 2,707 existing holdings. Its largest new stake was Schwab US TIPS ETF: 8,348,958 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $930M trimmed.
- Goldman Sachs's largest Q3 2022 buy was Schwab US TIPS ETF: 8,348,958 shares worth $216M.
- Goldman Sachs added most to Visa in Q3 2022, an estimated $2.06B increase.
- Goldman Sachs's biggest Q3 2022 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $930M.
- Goldman Sachs fully exited Mandiant, Inc. Common Stock in Q3 2022, selling an estimated $236M.
- Goldman Sachs's ten largest holdings make up 18% of its $396B portfolio in Q3 2022.
- Goldman Sachs opened 459 new positions and closed 646 in Q3 2022.
- Goldman Sachs's portfolio value fell 1.1% quarter-over-quarter to $396B.
Based on Goldman Sachs's 13F filing for Q3 2022, filed 14 Nov 2022.